Millennium Management’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Millennium Management’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,944	Closed	-$21K	–	7461
2022 Q4	$21K	Buy	+22,944	New	+$23.5K	﹤0.01%	6039
2022 Q2	–	Sell	-11,075	Closed	-$26K	–	7913
2022 Q1	$26K	Sell	11,075 -13,059	-54%	-$31.1K	﹤0.01%	6587
2021 Q4	$75K	Buy	+24,134	New	+$80.1K	﹤0.01%	6368
2021 Q3	–	Sell	-12,243	Closed	-$59K	–	7659
2021 Q2	$59K	Buy	+12,243	New	+$54.9K	﹤0.01%	6353
2019 Q4	–	Sell	-2,429	Closed	-$17K	–	4853
2019 Q3	$17K	Sell	2,429 -337	-12%	-$3.07K	﹤0.01%	4095
2019 Q2	$25K	Buy	2,766 +514	+23%	+$4.93K	﹤0.01%	3974
2019 Q1	$22K	Sell	2,252 -229	-9%	-$2.52K	﹤0.01%	3916
2018 Q4	$30K	Buy	2,481 +140	+6%	+$2.03K	﹤0.01%	3651
2018 Q3	$38K	Buy	2,341 +1,604	+218%	+$38.1K	﹤0.01%	3810
2018 Q2	$27K	Sell	737 -406	-36%	-$14K	﹤0.01%	3726
2018 Q1	$36K	Buy	+1,143	New	+$36.4K	﹤0.01%	3553
2017 Q4	–	Sell	-860	Closed	-$18K	–	4232
2017 Q3	$18K	Buy	+860	New	+$16K	﹤0.01%	3450
2015 Q2	–	Sell	-1,028	Closed	-$142K	–	4050
2015 Q1	$142K	Buy	+1,028	New	+$160K	﹤0.01%	3364

Other funds holding BLPH

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management's BLPH Position: Q1 2023 in Review

Millennium Management sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q1 2023, closing a stake of 22,944 shares — an estimated $21K sold.

Millennium Management first reported a position in BLPH in Q1 2015 and held it in 13 quarters. The position peaked at $142K in Q1 2015. 19 funds tracked by Wall St. Rank hold BLPH as of Q1 2023.

Millennium Management reported no remaining Bellerophon Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 22,944 Bellerophon Therapeutics, Inc. shares in Q1 2023, an estimated $21K.
Millennium Management first reported a position in Bellerophon Therapeutics, Inc. in Q1 2015 and held it in 13 quarters.
Millennium Management's Bellerophon Therapeutics, Inc. position peaked at $142K in Q1 2015.
19 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.